The Childhood Vaccine Schedule Was Cut From 17 to 11. A Court Just Froze It.

A process that hadn't changed since 1995 was overhauled, then legally frozen

Since 1995, the CDC's childhood immunization schedule has been developed through the Advisory Committee on Immunization Practices (ACIP), a body of independent medical experts who review clinical evidence and vote on recommendations, typically in the fall. That process changed dramatically starting June 9, 2025, when the HHS Secretary removed all 17 sitting ACIP members and appointed new ones.

On January 5, 2026, CDC's Acting Director approved a new childhood immunization schedule developed directly by federal officials rather than through the traditional ACIP process, cutting the number of universally recommended childhood vaccines from 17 to 11. This is described by Congressional Research Service analysis as an unprecedented departure from the established review process that had governed vaccine schedule updates for three decades.

The changes are currently on hold, not fully reversed

In American Academy of Pediatrics v. Kennedy, a federal district court in Massachusetts issued a stay on March 16, 2026, that halted implementation of the revised 2026 schedule, the newly appointed ACIP members, and all committee votes taken after June 11, 2025. Practically, this means the childhood and adult immunization schedules have reverted to their January 2025 versions while litigation continues, and the more restrictive 11-vaccine schedule currently has no legal effect.

Worth being precise about what actually changed and what didn't: HHS officials stated that all vaccines recommended as of the end of 2025 remain available and continue to be covered under Medicaid, CHIP, the Vaccines for Children program, and ACA marketplace plans, regardless of the schedule dispute. Major insurers, including the trade group AHIP and Blue Cross Blue Shield, separately committed to continue covering all vaccines that were CDC-recommended as of September 1, 2025, through at least the end of 2026.

The federal-state split matters enormously here

The federal government does not itself mandate vaccines, that authority belongs entirely to individual states, which set their own requirements for school attendance. States have historically used the CDC schedule as their baseline reference, but according to CIDRAP's ongoing state policy tracking, at least a dozen states are now explicitly tying their own recommendations to other sources, such as the American Academy of Pediatrics or their own state health officials, rather than the federal CDC schedule, specifically because of the current federal disruption.

This is creating genuine, growing divergence: some Democratic-leaning states have formed their own public health alliances specifically to counter federal changes, while red-state governors face political pressure in the opposite direction, toward loosening school vaccine mandates and expanding religious exemptions. The net effect is a widening state-by-state policy gap on top of the already-unresolved federal schedule dispute.

The international comparison used to justify the changes is itself contested

• The administration's stated goal, per Executive Order 14407, was to realign the U.S. schedule with practices in "peer-developed countries," specifically citing Denmark's more limited schedule as a model
• An independent comparison by journalist Amanda Ruggeri, published via CIDRAP in February 2026, examined pediatric vaccine schedules across 11 peer countries and found this framing incomplete: Switzerland, for example, universally recommends MenACWY, MenB, and rotavirus vaccines, which would put its own effective total at 17 vaccines, comparable to the prior U.S. schedule, not the reduced 11-vaccine standard
• Public health researchers and multiple medical societies, including the American College of Obstetricians and Gynecologists (ACOG), have responded by issuing their own independent guidance specifically because they say they no longer trust the federal recommending body to act in patients' best interest
• As of mid-2026, ACIP itself remains in legal limbo under the ongoing litigation, meaning there is, in practical terms, no fully functioning federal vaccine advisory body currently operating as originally structured

The core disagreement

Supporters of the schedule changes generally argue the prior process had become too closely aligned with industry and government interests, and that a leaner, more selectively targeted schedule better reflects genuine, updated risk-benefit analysis, framing the changes as a needed course correction rather than a reduction in child safety. Critics, including major medical societies and the CDC's own former ACIP members, argue the changes bypassed established scientific review procedures entirely, cite the specific example of dropping the newborn hepatitis B recommendation despite no new safety evidence undermining it, and warn that eroding a uniform national vaccination standard, even temporarily, risks preventable disease outbreaks and long-term public trust in vaccination broadly. The ongoing court stay means this is, as of now, a live legal and scientific dispute rather than settled federal policy in either direction.